SEC Company Response from Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Jan 22, 2010
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Jan. 22, 2010 · CIK: 0000890821 · Accession: 0001477932-10-000041
AI Filing Summary & Sentiment
Referenced dates: December 31, 2009
Show Raw Text
CORRESP
1
filename1.htm
secrespltr.htm
CARL N.
DUNCAN, ESQ., LLC
ATTORNEY
AT LAW
cduncan@cnduncanlaw.com
5718 Tanglewood
Drive
(301)
263-0200
Bethesda,
Maryland 20817
Fax (301)
576-5193
January
22, 2010
VIA
MESSENGER AND EDGAR FILING AS CORRESPONDENCE
David
Burton, Staff Accountant
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Mail Stop
3030
Washington,
D.C. 20549
Re: Spatializer
Audio Laboratories, Inc. (?SPZR?); File No. 0-26460
Reliability
Incorporated (?REAL?); File No. 0-07902
SPZR and REAL Forms 8-K
Filed December 30, 2009 Relating to Item 4.01
Dear Mr.
Burton:
This
letter is in response to the comments of the Division of Corporation Finance
staff (the ?Staff?) of the U.S. Securities and Exchange Commission (the
?Commission?) with respect to the above-referenced filings of Spatializer Audio
Laboratories, Inc. (?SPZR?) and Reliability Incorporated (?REAL?)
(col-lectively, the ?Companies?) as set forth in your respective comment letters
dated December 31, 2009 (the ?Comment Letters?). The Company hereby
responds to each of the Staff?s outstanding Comments.
For the
convenience of the Staff, we have reproduced the Staff?s comments from the
Comment Letter in
Italics. The responses to those Comments immediately follow
the reproduced Staff comments. In addition to submitting this letter
simultaneously herewith, we are sending you via messenger two (2) copies of this
letter being filed overnight as Correspondence on EDGAR. The Form
8-K/A referred to herein is being filed concurrently on EDGAR.
Please
note that there was only one accounting treatment at issue with regard to REAL
(dealing with development stage characterization), not the two issues associated
with SPZR (the development stage issue and the valuation issue growing out of a
July 2009 funding transaction). While the language of the two SEC
Comment Letters were identical, they should not have been. That
different treatment is ad-dressed as appropriate below.
By way of
background (and to provide on a supplemental basis information responsive to the
Comment Letters, very specifically Comment 2):
~ The
disagreement relating possible development stage treatment related to both SPZR
and REAL.
~ The
valuation issue related only to SPZR.
~ As
reflected in the prior auditor?s respective letter dated December 31, 2009 and
appended to the appropriate Form 8-K, there were no further disagreements with
Schumacher on accounting principle or practice, financial statement disclosure
or auditing scope or procedure.
~ With
regard to development stage treatment:
-
The
issue arose during the Company?s third quarter, the period ended September
30, 2009.
-
Each
of the Companies were previously operating entities going back at least 20
years.
-
Because
of changed circumstances (sale of the primary business in the case of REAL
and going through a Chapter 11 Bankruptcy in the case of
SPZR), each became a shell and each Com-pany has so
characterized.
-
Each
of the Companies believe that it is not a development stage company, based
on accounting pronouncements, since it is dormant and not presently
pursuing any business opportunity other than as a shell
company.
David
Burton
United
States Securities and Exchange Commission
Division
of Corporation Finance
Page 2
January
22, 2010
-
In
contrast, Schumacher believed that a shell company is by definition of a
development stage company.
-
As
evidenced by proper filing of the respective Form 10-Q for the periods
ending June 30, 2009 and September 30, 2009, SPZR and REAL has each
concluded the development stage company issue has been
resolved.
-
SPZR
and REAL recognize each is required to change its accounting treatment
when, in the fu-ture, becomes a development stage
company.
~ The
second issue pertinent only to SPZR) involved the valuation associated with the
Company?s July 7, 2009 stock issuance:
-
This
dispute culminated in the voiding of the transaction as discussed above
and in SPZR?s Form 8-K filed November 23, 2009.
-
With
regard to the valuation issue, the issue arose during the third quarter,
the period ended September 30, 2009.
-
Even
though the purchase of restricted shares are typically purchased at a
discount to market price, the SPZR shares at issue were purchased at the
average closing price per share for the 10 days prior?i.e., without a
discount.
-
Schumacher
believed that the valuation should be based on the sale price on
comparable shells (not the per share market value price as in this
case).
-
The
issue became moot when an outside consultant noted that the price per
share paid was below the Company?s .01 par value per share, an ultra vires
act.
-
An
immediate rescission was effected per the Schumacher corrective action
recommendation, thereby voiding the prior transaction.
-
Since
these matters all occurred within SPZR?s third quarter, no restatement for
prior periods was or is required.
Item
4-01. Changes in Registrant?s Certifying
Accountant
1.
Please
clarify whether, during your two most recent quarters ended June 30 and
September 30, 2009 and the subsequent interim period through December 30,
2009 before your former auditor was terminated, you had any disagreements
with your former auditor on any matter of accounting principle or
practice, financial statement disclosure, or auditing scope or
procedure.
Response
to Comment 1: Noting that the prior auditor provided its ?no
disputes? letter respectively for SPZR and REAL (and each was attached to the
respective Form 8-K filed December 31, 2009), the Companies are satisfied that
the disclosures in their respective Form 8-K filed are accurate and do not
require amendment. The disclosures that follow are being submitted
supplemental per the Staff?s request.
2.
Refer
to paragraph of the Form 8-K where you identify accounting
disagreements. For each disagreement, please tell us
supplementally:
*
the period to which the disagreement
relates;
*
the nature of the disagreement including the registrant?s position and the
former accountant?s position at the time of the
disagreement;
*
the financial statement amounts
involved;
*
why the disagreement could not be resolved or how it was
resolved;
*
how and by whom the amounts were determined;
[and]
*
whether you restated (or intend to restate) any prior period for any
adjustment, and if not, why.
David
Burton
United
States Securities and Exchange Commission
Division
of Corporation Finance
Page 3
January
22, 2010
Response to
Comment 2: In fact, there was only one disagreement with
regard to Reliability Incorporated (?REAL?), specifically whether the Company
should be filing as a development stage company. The valuation issue was unique to
Spatializer Audio Laboratories, Inc. (?SPZR?) and, accordingly, your (i)
valuation comment as to REAL was misplaced and (ii) we request the Staff waive
that portion of your REAL Comment Letter relating to
valuation. For a breakout of the info here requested on a
Company and issue by issue basis, see the background outlined above.
3.
With
respect to the disagreements with the former accountants, amend the Form
8-K to provide all information required by Item 304(a)(1)(v)(B)-(D)) of
Regulation S-K, as applicable.
Response to Comment
3: We believe all disclosures so required were made in
the respective Form 8-K.
4.
Please
also note the requirements of Item 304(b) of Regulation S-K. If
there were any material transactions or events similar to those involved
in the disagreement that you accounted for or disclosed differently than
your former accountant would have concluded was required, revise to
provide all of the disclosures required by Item 304(b) of Regulation
S-K.
Response to Comment
4: We believe all disclosures so required were made in the
respective Form 8-K.
5.
Provide
us with any letter or written communication to and from the former
accountants regarding any disagreement so reportable events to management
or the Audit Committee.
Response to Comment
5: The Companies advise me that communications relating to the
developmental stage issue were done orally and the Companies believe all
disclosures so required were made in the respective Form 8-K. The
communications relating to the valuation issue associated with SPZR dealt with
an exchange between Schumacher & Associates, Inc. as to the fairness of the
price paid but, since the transaction was voided (at the suggestion of such
auditing firm once it was advised that the sale was ultra vires--since less than
the SPZR par value), those communications would appear to be moot and have been
omitted. (SPZR, of course, will submit should the staff still
so request.)
6.
To
the extent that you amend the Form 8-K to comply with our comments, please
obtain and file an Exhibit 16 letter from the former accountant stating
whether the accountant agrees with your Item 304 disclosures, or the
extent to which the accountant does not
agree.
Response to Comment
6: For the reasons outline above, there neither a dispute with
the departing auditory and there is no need to file an Amendment to either or
both Companies? Form 8-K).
Since
there is no outstanding dispute, no letter is being provided by
Schumacher. The Staff is referred instead to the ?no disputes? letter
prepared by Schumacher and filed as an exhibit to the Form 8-K filed December
31, 2009 by SPZR and REAL, respectively.
David
Burton
United
States Securities and Exchange Commission
Division
of Corporation Finance
Page 4
January
22, 2010
We, of
course, stand ready to respond to any further questions you may have and/or if
you require additional information. We appreciate your consideration
of this matter and trust the Staff has no further comments.
Sincerely,
/s/ Carl N. Duncan
Carl N.
Duncan
cc: Jay
Gottlieb
Gregg Schneider
Michael C. Pearce
Dave Sherwood
Mick Schumacher/Lois
Huston
ACKNOWLEDGED
AND AGREED AS
TO
FOREGOING FACTUAL ELEMENTS
_/s/ Jay
Gottlieb________________________
Jay
Gottlieb, Chairman and President Respectively of
Spatializer
Audio Laboratories, Inc.
and
Reliability Incorporated